Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-01-19

FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for NASACORT ALLERGY 24HR (Triamcinolone Acetonide) from Chattem, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NASACORT ALLERGY 24HR (TRIAMCINOLONE ACETONIDE)

Snippet

SUPPL AP for NASACORT ALLERGY 24HR (TRIAMCINOLONE ACETONIDE)